Charles River Laboratories ROA 2010-2025 | CRL

Current and historical return on assets (ROA) values for Charles River Laboratories (CRL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Charles River Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $-0.04B $7.58B -0.48%
2024-12-31 $0.01B $7.53B 0.14%
2024-09-30 $0.42B $8.00B 5.24%
2024-06-30 $0.44B $7.95B 5.53%
2024-03-31 $0.44B $8.15B 5.60%
2023-12-31 $0.47B $8.20B 6.06%
2023-09-30 $0.47B $7.61B 6.18%
2023-06-30 $0.48B $7.77B 6.34%
2023-03-31 $0.50B $7.70B 6.55%
2022-12-31 $0.49B $7.60B 6.56%
2022-09-30 $0.44B $7.38B 6.01%
2022-06-30 $0.44B $7.53B 6.18%
2022-03-31 $0.42B $7.08B 6.06%
2021-12-31 $0.39B $7.02B 5.88%
2021-09-30 $0.40B $7.06B 6.32%
2021-06-30 $0.40B $6.72B 6.82%
2021-03-31 $0.38B $5.81B 6.90%
2020-12-31 $0.36B $5.49B 6.89%
2020-09-30 $0.30B $5.21B 5.92%
2020-06-30 $0.27B $5.24B 5.50%
2020-03-31 $0.25B $5.20B 5.19%
2019-12-31 $0.25B $4.69B 5.65%
2019-09-30 $0.23B $4.58B 5.46%
2019-06-30 $0.22B $4.63B 5.41%
2019-03-31 $0.23B $3.93B 5.93%
2018-12-31 $0.23B $3.86B 6.25%
2018-09-30 $0.14B $3.80B 4.03%
2018-06-30 $0.13B $3.87B 4.07%
2018-03-31 $0.13B $3.00B 4.46%
2017-12-31 $0.12B $2.93B 4.37%
2017-09-30 $0.20B $2.87B 7.17%
2017-06-30 $0.18B $2.77B 6.77%
2017-03-31 $0.17B $2.70B 6.08%
2016-12-31 $0.16B $2.71B 6.04%
2016-09-30 $0.14B $2.69B 5.90%
2016-06-30 $0.14B $2.76B 6.29%
2016-03-31 $0.16B $2.10B 7.66%
2015-12-31 $0.15B $2.07B 7.66%
2015-09-30 $0.15B $2.03B 7.59%
2015-06-30 $0.14B $1.89B 7.52%
2015-03-31 $0.13B $1.85B 6.79%
2014-12-31 $0.13B $1.87B 6.97%
2014-09-30 $0.12B $1.84B 6.75%
2014-06-30 $0.12B $1.86B 6.89%
2014-03-31 $0.11B $1.65B 6.66%
2013-12-31 $0.10B $1.63B 6.34%
2013-09-30 $0.10B $1.64B 6.32%
2013-06-30 $0.09B $1.62B 5.83%
2013-03-31 $0.10B $1.60B 6.09%
2012-12-31 $0.10B $1.59B 6.14%
2012-09-30 $0.11B $1.57B 6.74%
2012-06-30 $0.10B $1.55B 6.53%
2012-03-31 $0.10B $1.56B 6.50%
2011-12-31 $0.11B $1.56B 6.61%
2011-09-30 $-0.26B $1.59B -15.48%
2011-06-30 $-0.31B $1.71B -16.85%
2011-03-31 $-0.32B $1.75B -16.80%
2010-12-31 $-0.34B $1.73B -16.57%
2010-09-30 $0.02B $2.08B 1.11%
2010-06-30 $0.09B $2.16B 3.94%
2010-03-31 $0.11B $2.19B 4.85%
2009-12-31 $0.11B $2.20B 5.28%
Sector Industry Market Cap Revenue
Medical Medical Services $7.779B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.621B 26.94
CVS Health (CVS) United States $84.680B 10.52
Elevance Health (ELV) United States $78.955B 10.19
Cencora (COR) United States $57.765B 20.10
DiDi Global (DIDIY) China $23.297B 24.75
Natera (NTRA) United States $21.640B 0.00
Labcorp Holdings (LH) United States $21.549B 17.48
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.690B 0.00
Solventum (SOLV) United States $12.990B 13.75
CochLear (CHEOY) Australia $12.847B 0.00
ICON (ICLR) Ireland $12.241B 11.38
Revvity (RVTY) United States $11.865B 20.42
Viatris (VTRS) United States $10.868B 3.73
Avantor (AVTR) United States $9.370B 13.61
Medpace Holdings (MEDP) United States $9.269B 24.62
HealthEquity (HQY) United States $8.917B 39.06
Sonic Healthcare (SKHHY) Australia $8.417B 0.00
Caris Life Sciences,�Inc (CAI) United States $6.688B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.952B 29.17
BrightSpring Health Services (BTSG) United States $3.769B 34.58
Sotera Health (SHC) United States $3.290B 18.69
Surgery Partners (SGRY) United States $2.853B 37.10
Alignment Healthcare (ALHC) United States $2.712B 0.00
Concentras Parent (CON) United States $2.615B 15.11
Organon (OGN) United States $2.587B 2.75
GeneDx Holdings (WGS) United States $2.432B 93.65
Progyny (PGNY) United States $2.080B 45.79
PACS (PACS) United States $1.972B 0.00
Ardent Health (ARDT) United States $1.970B 8.40
Premier (PINC) United States $1.805B 13.70
GoodRx Holdings (GDRX) United States $1.729B 34.57
Teladoc Health (TDOC) United States $1.493B 0.00
Establishment Labs Holdings (ESTA) $1.271B 0.00
Pediatrix Medical (MD) United States $1.159B 8.82
CareDx (CDNA) United States $1.072B 16.74
Agilon Health (AGL) United States $0.989B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
AMN Healthcare Services Inc (AMN) United States $0.846B 7.92
Nutex Health (NUTX) United States $0.766B 11.59
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.610B 4.11
InnovAge Holding (INNV) United States $0.574B 0.00
LifeMD (LFMD) United States $0.544B 0.00
SBC Medicals (SBC) United States $0.504B 0.00
Sonida Senior Living (SNDA) United States $0.468B 0.00
Auna S.A (AUNA) Luxembourg $0.465B 10.47
Omada Health (OMDA) $0.450B 0.00
So-Young (SY) China $0.423B 0.00
Enhabit (EHAB) United States $0.370B 30.42
Performant Healthcare (PHLT) United States $0.333B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.324B 0.00
Beauty Health (SKIN) United States $0.265B 0.00
Oncology Institute (TOI) United States $0.223B 0.00
DocGo (DCGO) United States $0.158B 25.83
Pheton Holdings (PTHL) China $0.128B 0.00
Sera Prognostics (SERA) United States $0.102B 0.00
KindlyMD (NAKA) United States $0.078B 0.00
IceCure Medical (ICCM) Israel $0.067B 0.00
Ascend Wellness Holdings (AAWH) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.055B 0.00
Biodesix (BDSX) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
Basel Medical Group (BMGL) Singapore $0.034B 0.00
OSR Holdings (OSRH) United States $0.026B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00